Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Industry: Biotechnology

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It has two lentiviral vector (LVV) programs under clinical testing to treat fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells; and three LVV programs for the treatment of other rare genetic diseases, as well as an adeno-associated viral vector program, which is under preclinical development. The company has collaboration agreements with Lund University, Sweden; and Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, as well as a strategic research collaboration agreement with Stanford University School of Medicine. Rocket Pharmaceuticals, Inc. is headquartered in New York, New York.

Current Quote*
Last: $18.430
Change: -0.030
Book: $3.704
Volume: 155,736

As Of: 03/20 13:38 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol RCKT

Graphs for RCKT


3 Month Graph


6 Month Graph


1 Year Graph